Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Deep brain stimulation is known to treat the symptoms of stiffness, slow movement, and tremor in people with Parkinson’s disease. Researchers are now a step closer to understanding exactly how this electrical stimulation of specific areas in the brain works.

Schematic illustration of ‘striatal damping’ by antidromic activation of striatopallidal axons. DA, dopaminergic; SNpc, substantia nigra pars compacta © James Fitzgerald
Schematic illustration of ‘striatal damping’ by antidromic activation of striatopallidal axons. DA, dopaminergic; SNpc, substantia nigra pars compacta

It is thought that part of the underlying problem for people with Parkinson’s is the overactivity of certain nerve cells. This overactivity affects the way that information flows from one circuit within the brain to another. In a paper published in the Journal of Neuroscience, researchers describe an experiment using deep brain stimulation that has demonstrated how the technique improves information flow between circuits, probably by calming down the overactive cells.

The researchers tested eye movements in 14 patients and 10 healthy controls. They electrically stimulated an area of the brain called the globus pallidus interna. They showed that this deep brain stimulation partially reverses deficits in voluntary control of eye movements, restoring some control.

This is an exciting finding because it suggests that deep brain stimulation might be able to address some of the non-motor aspects of Parkinson’s Disease
- Chrystalina Antoniades, lead author of the study.

The experiment showed improvement in information transfer between higher, cognitive, brain circuits and lower-level motor systems. This may mean that stimulation of the globus pallidus interna could have a positive effect on those symptoms of Parkinson’s disease that are not directly movement-related.

Read the paper online…

Read more about OcuLab…

Similar stories

How to use the science of the body clock to improve our sleep and health

Professor Russell Foster has written a new book about circadian neuroscience which is published by Penguin this week. This book review by Jacqueline Pumphrey was first published on the University of Oxford website.

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.

MRC BNDU receives a Wellcome Collaborative Award for Parkinson’s research

We are delighted to announce that the MRC Brain Network Dynamics Unit has received Collaborative Award funding from Wellcome for a substantial multi-year research programme designed to advance the understanding of why dopamine-producing nerve cells are especially vulnerable in Parkinson’s.

Unique study of vascular disease reaches 20th anniversary

The only project of its kind anywhere that studies patients with all types of acute vascular events - including strokes, heart attacks, aneurysms - in order to develop better diagnostic tests and treatments celebrates its 20th anniversary this month.

Little understood brain region linked to how we perceive pain

A new DPAG-led review paper, published in the journal Brain, has shown that a poorly understood region of the brain called the claustrum may play an important role in how we experience pain.